These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6245791)

  • 1. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
    Dow LW; Bell DE; Poulakos L; Fridland A
    Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W; Chubb S; Alexander L; Montgomery JA
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW; Major PP; Munroe D; Egan M; Herrick D
    Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
    Verhoef V; Sarup J; Fridland A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
    Müller WE; Maidhof A; Zahn RK; Shannon WM
    Cancer Res; 1977 Jul; 37(7 Pt 1):2282-90. PubMed ID: 301056
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.
    Brockman RW; Schabel FM; Montgomery JA
    Biochem Pharmacol; 1977 Nov; 26(22):2193-6. PubMed ID: 563233
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.
    Spriggs D; Robbins G; Mitchell T; Kufe D
    Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL
    Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the growth inhibition and metabolism of 2'-deoxy-2'-fluorocytidine in cultured human lymphoblasts.
    Brox LW; LePage GA; Hendler SS; Shannahoff DH
    Cancer Res; 1974 Aug; 34(8):1838-42. PubMed ID: 4526299
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA
    Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
    Huang P; Plunkett W
    Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
    Van den Neste E; Cardoen S; Offner F; Bontemps F
    Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblasts.
    Barchi JJ; Cooney DA; Ahluwalia GS; Gharehbaghi K; Covey JM; Hochman I; Paull KD; Jayaram HN
    J Exp Ther Oncol; 1996 May; 1(3):191-203. PubMed ID: 9414404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
    Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA
    Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.
    Sirotnak FM; Chello PL; Dorick DM; Montgomery JA
    Cancer Res; 1983 Jan; 43(1):104-9. PubMed ID: 6847758
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE; Selner M; Phillips JR
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Juranka P; Chan VL
    Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.